Is M1Z undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
0/6
Valuation Score 0/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of M1Z when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: M1Z (€12.95) is trading above our estimate of fair value (€11.77)
Significantly Below Fair Value: M1Z is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for M1Z?
Key metric: As M1Z is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.
The above table shows the Price to Earnings ratio for M1Z. This is calculated by dividing M1Z's market cap by their current
earnings.
What is M1Z's PE Ratio?
PE Ratio
36.2x
Earnings
US$1.78b
Market Cap
US$64.02b
M1Z key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Price-To-Earnings vs Industry: M1Z is expensive based on its Price-To-Earnings Ratio (36.2x) compared to the European Banks industry average (7.3x).
Price to Earnings Ratio vs Fair Ratio
What is M1Z's PE Ratio
compared to its
Fair PE Ratio?
This is the expected PE Ratio taking into
account the company's forecast earnings growth, profit margins
and other risk factors.
M1Z PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio
36.2x
Fair PE Ratio
17.7x
Price-To-Earnings vs Fair Ratio: M1Z is expensive based on its Price-To-Earnings Ratio (36.2x) compared to the estimated Fair Price-To-Earnings Ratio (17.7x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
The above table shows the analyst M1Z forecast and predictions for the stock price in 12 month’s time.
Date
Share Price
Average 1Y Price Target
Dispersion
High
Low
1Y Actual price
Analysts
Current
€12.95
€15.05
+16.3%
16.0%
€17.94
€7.55
n/a
20
Nov ’25
€13.28
€13.90
+4.7%
15.1%
€17.09
€7.39
n/a
20
Oct ’25
€12.16
€13.36
+9.9%
15.5%
€16.55
€7.16
n/a
20
Sep ’25
€13.30
€12.96
-2.5%
16.5%
€16.29
€7.24
n/a
19
Aug ’25
€10.64
€12.56
+18.1%
14.9%
€15.62
€7.35
n/a
19
Jul ’25
€11.55
€12.19
+5.6%
15.6%
€14.98
€7.49
n/a
19
Jun ’25
€11.05
€11.48
+3.9%
16.9%
€14.74
€7.37
n/a
17
May ’25
€10.30
€11.77
+14.3%
13.9%
€15.02
€7.98
n/a
17
Apr ’25
€11.05
€11.07
+0.2%
18.7%
€14.90
€5.59
n/a
17
Mar ’25
€10.26
€10.62
+3.5%
19.3%
€14.76
€5.54
n/a
17
Feb ’25
€8.20
€9.66
+17.9%
19.2%
€14.72
€5.52
n/a
17
Jan ’25
€7.54
€9.34
+23.9%
20.2%
€14.86
€5.57
n/a
17
Dec ’24
€7.37
€9.11
+23.7%
20.4%
€14.58
€5.47
n/a
17
Nov ’24
€7.85
€8.97
+14.2%
25.0%
€15.07
€3.77
€13.28
17
Oct ’24
€6.82
€8.06
+18.2%
23.3%
€10.41
€3.78
€12.16
16
Sep ’24
€6.29
€7.76
+23.3%
23.9%
€10.14
€3.69
€13.30
16
Aug ’24
€7.08
€7.44
+5.1%
27.8%
€11.22
€3.62
€10.64
17
Jul ’24
€7.12
€7.36
+3.4%
27.7%
€11.37
€3.67
€11.55
17
Jun ’24
€6.15
€7.04
+14.6%
32.5%
€11.47
€2.77
€11.05
17
May ’24
€4.59
€6.40
+39.3%
35.2%
€11.39
€2.73
€10.30
18
Apr ’24
€4.38
€6.60
+50.7%
34.1%
€11.76
€2.82
€11.05
18
Mar ’24
€4.48
€6.62
+47.8%
34.7%
€11.72
€2.81
€10.26
18
Feb ’24
€4.20
€6.21
+47.8%
40.7%
€11.41
€2.76
€8.20
18
Jan ’24
€3.86
€6.49
+68.1%
38.5%
€11.61
€2.81
€7.54
18
Dec ’23
€4.18
€6.73
+61.0%
37.8%
€11.91
€3.17
€7.37
19
Nov ’23
€5.25
€7.24
+37.9%
41.3%
€12.70
€3.35
€7.85
17
Analyst Forecast: Target price is less than 20% higher than the current share price.